EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular basis and dual ligand regulation of tetrameric estrogen receptor α/14-3-3ζ protein complex

Bente A Somsen, Eline Sijbesma, Seppe Leysen, Karolina Honzejkova, Emira J Visser, Peter J Cossar, Tomáš Obšil, Luc Brunsveld, Christian Ottmann

Journal of Biological Chemistry · 2023

DOI: 10.1016/j.jbc.2023.104855 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023. Verfasst von Bente A Somsen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering and Institute for Complex Molecular Systems, Laboratory of Chemical Biology, Eindhoven University of Technology,…. Hauptthemen laut MEDLINE: 14-3-3 Proteins, Estrogen Receptor alpha. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Helmholtz Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutic strategies targeting nuclear receptors (NRs) beyond their endogenous ligand binding pocket have gained significant scientific interest driven by a need to circumvent problems associated with drug resistance and pharmacological profile. The hub protein 14-3-3 is an endogenous regulator of various NRs, providing a novel entry point for small molecule modulation of NR activity. Exemplified, 14-3-3 binding to the C-terminal F-domain of the estrogen receptor alpha (ERα), and small molecule stabilization of the ERα/14-3-3ζ protein complex by the natural product Fusicoccin A (FC-A), was demonstrated to downregulate ERα-mediated breast cancer proliferation. This presents a novel drug discovery approach to target ERα; however, structural and mechanistic insights into ERα/14-3-3 complex formation are lacking. Here, we provide an in-depth molecular understanding of the ERα/14-3-3ζ complex by isolating 14-3-3ζ in complex with an ERα protein construct comprising its ligand-binding domain (LBD) and phosphorylated F-domain. Bacterial co-expression and co-purification of the ERα/14-3-3ζ complex, followed by extensive biophysical and structural characterization, revealed a tetrameric complex between the ERα homodimer and the 14-3-3ζ homodimer. 14-3-3ζ binding to ERα, and ERα/14-3-3ζ complex stabilization by FC-A, appeared to be orthogonal to ERα endogenous agonist (E2) binding, E2-induced conformational changes, and cofactor recruitment. Similarly, the ERα antagonist 4-hydroxytamoxifen inhibited cofactor recruitment to the ERα LBD while ERα was bound to 14-3-3ζ. Furthermore, stabilization of the ERα/14-3-3ζ protein complex by FC-A was not influenced by the disease-associated and 4-hydroxytamoxifen resistant ERα-Y537S mutant. Together, these molecular and mechanistic insights provide direction for targeting ERα via the ERα/14-3-3 complex as an alternative drug discovery approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

14-3-3 ProteinsEstrogen Receptor alphaHumansLigandsTamoxifenProtein BindingDrug DiscoveryEstrogen Antagonists

Stichwörter der Autor:innen

14-3-3 proteinEstrogen ReceptorNuclear receptorsPPI stabilizationprotein–protein interactions

Substanzen

14-3-3 ProteinsafimoxifeneEstrogen Receptor alphaLigandsTamoxifenEstrogen Antagonists

Autor:innen und Institutionen

  • Department of Biomedical Engineering and Institute for Complex Molecular Systems, Laboratory of Chemical Biology, Eindhoven University of Technology, Eindhoven, The Netherlands.
  • Department of Physical and Macromolecular Chemistry, Faculty of Science, Charles University, Prague, Czech Republic.
  • Department of Biomedical Engineering and Institute for Complex Molecular Systems, Laboratory of Chemical Biology, Eindhoven University of Technology, Eindhoven, The Netherlands. Electronic address: l.brunsveld@tue.nl.
  • Department of Biomedical Engineering and Institute for Complex Molecular Systems, Laboratory of Chemical Biology, Eindhoven University of Technology, Eindhoven, The Netherlands. Electronic address: c.ottmann@tue.nl.

Förderung

  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek
  • Helmholtz Association

Zitieren

APA

Somsen, B. A., Sijbesma, E., Leysen, S., Honzejkova, K., Visser, E. J., Cossar, P. J., Obšil, T., Brunsveld, L., & Ottmann, C. (2023). Molecular basis and dual ligand regulation of tetrameric estrogen receptor α/14-3-3ζ protein complex. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.104855

Vancouver

Somsen BA, Sijbesma E, Leysen S, Honzejkova K, Visser EJ, Cossar PJ, et al. Molecular basis and dual ligand regulation of tetrameric estrogen receptor α/14-3-3ζ protein complex. Journal of Biological Chemistry. 2023. doi:10.1016/j.jbc.2023.104855

BibTeX
@article{Somsen2023,
  author = {Somsen, Bente A and Sijbesma, Eline and Leysen, Seppe and Honzejkova, Karolina and Visser, Emira J and Cossar, Peter J and Obšil, Tomáš and Brunsveld, Luc and Ottmann, Christian},
  title = {Molecular basis and dual ligand regulation of tetrameric estrogen receptor α/14-3-3ζ protein complex},
  journal = {Journal of Biological Chemistry},
  year = {2023},
  doi = {10.1016/j.jbc.2023.104855}
}
Kostenlos starten →